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Abstract
Transpeptidation catalyzed by sortase A allows the preparation of proteins that are site-specifically 
and homogeneously modified with a wide variety of functional groups, such as fluorophores, PEG 
moieties, lipids, glycans, bioorthogonal reactive groups and affinity handles. This protocol 
describes immobilization of sortase A on a solid support (sepharose beads). Immobilization of 
sortase A simplifies downstream purification of a protein of interest after labeling of its N- or C- 
terminus. Small batch and larger scale continuous flow reactions require only a limited amount of 
enzyme. The immobilized enzyme can be reused for multiple cycles of protein modification 
reactions. The described protocol also works with a Ca2+-independent variant of sortase A with 
increased catalytic activity. This heptamutant variant of sortase A (7M) was generated by 
combining previously published mutations and this immobilized enzyme can used for the 
modification of calcium-senstive substrates or in instances where low temperatures are needed. 
Preparation of immobilized sortase A takes 1–2 days. Batch reactions take 3–12 hours and flow 
reactions proceed at 0.5 mL per hour, depending on the geometry of the reactor used.
Keywords
Protein synthesis; flow reactor; immobilized enzyme; protein modification; continuous flow 
reaction; batch reaction; sortase; calcium independent sortase A
Correspondence should be addressed to: Hidde L. Ploegh, Whitehead Institute for Biomedical Research, 9 Cambridge Center, 
Cambridge, MA 02142, Phone: (617) 324-2031, Fax: (617) 452-3566, ploegh@wi.mit.edu.
5These authors contributed equally
6Current address: Bio-Organic Chemistry, Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands
Author contributions
MDW, CPG and HLP conceived of the idea; MDW, TW, CST, CPG and AEMB performed the immobilization reactions and 
optimized the sortase reactions in batch and in flow; JRI developed the heptamutant sortase and ZL and LK assisted in sortase and 
protein production; MDW, TW, CST, CPG, JRI and HPL wrote the manuscript; SDG and HLP supervised the project.
Competing financial interest.
The authors declare no competing financial interest.
HHS Public Access
Author manuscript
Nat Protoc. Author manuscript; available in PMC 2016 March 01.
Published in final edited form as:
Nat Protoc. 2015 March ; 10(3): 508–516. doi:10.1038/nprot.2015.026.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
CATEGORIES
Isolation; separation and purification; Protein functionalization; Chemical Modification
Introduction
Proteins are attractive therapeutics, diagnostic tools and imaging agents, but their application 
as such often requires the installation of additional, non-genetically encoded functional 
groups. Various methods for protein labeling exist, but these often lack specificity and thus 
may compromise protein function. Attachment of polyethylene glycol (PEGylation), 
incorporation of dyes and other functional groups, as well as the generation of antibody-drug 
conjugates usually rely on modification of endogenous cysteine or lysine residues, which 
can lead to heterogeneous products, unspecific labeling and loss of protein function. For 
example, PEGylation, while increasing circulatory half-life 1, may cause a decrease or even 
loss of biological activity due to the chemical modification(s) imposed 2. Such results have 
also been observed when preparing antibody-drug conjugates 3. Heterogeneity after labeling 
may confound accurate dosing and complicate drug approval and pharmaceutical 
production.
The transpeptidation reaction catalyzed by sortase A allows site-specific protein 
modification with functional groups of choice, such as dyes 4, biotin 4, click-handles 5, 
nucleic acids 6, carbohydrates 7, lipids 8, and PEG moieties 9. The modification is installed 
in a controlled and site-specific fashion, in near-quantitative yields. Engineered variants of 
Sortase A with increased catalytic acitivity allow more rapid protein modification at lower 
temperatures, enabling a wider range of applications10.
Advantages of sortase-mediated reactions using immobilized sortase
A sortase-mediated reaction is comprised of enzyme, substrate and the desired functional 
group to be installed. This reaction allows functionalization of a (poly)peptide of choice at 
its N-terminus 11–13, C-terminus 4,14, at a specific internal site 15,16, or at both termini using 
two orthogonal sortases 11. Upon completion of the reaction, the labeled product requires 
further purification. To this end, both sortase and the input substrate can be engineered to 
contain an affinity tag, most commonly His6, at their C-termini. This tag is lost upon 
successful transpeptidation of substrate, so that His-tagged sortase A and unreacted substrate 
can be removed in a single step by affinity chromatography on a Ni-NTA matrix. Gel 
filtration can then be used for further purification of the product by removal of excess free 
peptide 17. Affinity chromatography cannot always resolve input material from labeled 
product, either because both species contain an affinity tag (as applied to N-terminal 
labeling reactions 11) or because the intrinsic properties of substrate and/or product cause 
non-specific binding to the affinity resin 15. In these situations, product purification by gel 
filtration and/or ion exchange chromatography are possible alternatives. As described in this 
report, the use of immobilized sortase accelerates the purification process and obviates the 
need for removal of sortase.
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A concern frequently raised regarding sortase-mediated reactions is the amount of sortase A 
required, as enzyme and substrate are typically used at near equimolar concentrations. This 
is of particular worry for large-scale reactions, which therefore require sizable amounts of 
enzyme, whose presence can complicate downstream purification steps in large-scale 
applications. Immobilizing sortase A on a solid support can overcome these technical 
limitations as it allows using sortase A in continuous-flow reactions. The prepared sortase 
columns can be re-used, affording scale-up of the reactions and minimizing batch-to-batch 
variation. The amount of sortase A required for large-scale reactions may thus be decreased 
and downstream processing is simplified. Even for small-scale batch reactions, the use of 
immobilized sortase facilitates analysis of reactions by simplifying the composition of the 
mixture of proteins in solution. Sortase A mutants with increased activity can further 
decrease the amount of sortase needed for large-scale reactions. They can be used at lower 
concentrations, either in solution or when immobilized. Moreover, these mutant sortases can 
function at reduced temperatures (4 °C), compared to 20–37 °C used for sortagging10 with 
the wild type enzyme facilitating labeling of sensitive proteins. However, both wild type 
Sortase A and the evolved pentamutant sortase (5M) require Ca2+ as a cofactor, 
compromising their utility in applications in the presence of Ca2+ or in combination with 
buffers such as phosphate-buffered saline. We recently described a sortase A variant, termed 
heptamutant sortase A (7M) , which combines the pentamutant version with increased 
catalytic activity with mutations that render sortase calcium independent18, resulting in an 
enzyme with increased activity and no longer requiring Ca2+ (Fig. 2)19. The immobilized 
variant of this enzyme facilitated straightforward modification of aerolysin and greatly 
simplified the purification of the modified product.
This protocol describes immobilization of S. aureus sortase A and its variants on Sepharose 
beads for modification of either the N- or C-terminus of a substrate in small batch or in 
continuous flow mode for larger-scale reactions (see Fig. 1 for overall schematic). The 
continuous flow mode is most effectively applied to C-terminal labeling reactions, where 
substrate and modifying nucleophile are provided in solution, but may also be applied to N-
terminal reactions by pre-reacting the resin with an LPXTG-containing probe to boost 
yields. Prior to performing conjugation reactions using the continuous flow system, 
suitability of the designated protein as a substrate for sortase A should be evaluated in small 
batch reactions. Detailed protocols for production of sortases, sortase substrate design, 
peptide synthesis, and sortase reactions in solution are provided in previous protocols20,21. 
Sortase A immobiliziation has been previously described using a different strategy than 
detailed in this protocol22. The protocol outlined here offers a more rapid, covalent 
immobilization procedure, as well as the use of the calcium-independent heptamutant 
sortase A to increase the utility of the reaction. In immobilized form, the heptamutant 
sortase enables a reduction in the amount of enzyme needed, while accelerating the reaction 
in a wide array of buffers.
Limitations of the continuous-flow method
Purification and immobilization of sortase, as well as packing a column or cartridge with the 
sortase-conjugated beads for use in a continuous-flow reaction takes time. However, the 
ability to reuse immobilized sortase saves both time and resources. Flow reactions for N-
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terminal labeling require slightly longer reaction times due to the pre-equilibration of the 
column with an LPXTG-containing probe. Non-specific binding of the substrate of interest 
or of the label itself may interfere with the immobilized sortase labeling reaction if blocking 
procedures are not carefully followed. In our experience, non-specific binding is negligible 
(Fig. 3 and 4). Nonetheless, the occurrence and extent of non-specific binding must be 
determined empirically for every reaction. A higher concentration of immobilized sortase 
may be required to achieve a similar degree of labeling when compared to soluble sortase, as 
not all sortase active sites may be equally accessible as a consequence of immobilization.
Experimental design and general considerations
Sortase A or derivatives with increased activity and/or Ca2+ independence, including the 
heptamutant sortase A, are expressed and purified as described20, followed by 
immobilization on commercially available cyanogen bromide-activated Sepharose. Free 
amines of sortase A react with the activated resin, forming an iso-urea or an imidocarbonate 
derivate (Fig. 1A). For small batch reactions, the sortase-containing beads are mixed with 
substrate and labeled in a microcentrigue tube and reacted for 3–12 hrs at 37 °C The 
heptamutant sortase A described here can be used at reduced temperatures, as low as 4 °C. 
Small scale test reactions are performed to optimize the labeling time, labeling temperature 
and probe-to-substrate ratio. These small batch reactions are also more rapid for small scale 
labeling reactions. For larger scale preparative reactions we pack a column with 
immobilized sortase A (10 mg of enzyme in a 5 x 70 mm column), and equilibrate it with 
sortase reaction buffer at 37 °C. The optimal labeling temperature and probe-to-substrate 
ratio as determined in the batch reaction provide good starting conditions for the 
optimization of the flow reaction. We vary the flow-rate and determine the conversion of the 
substrate by taking aliquots and analyzing them by SDS-PAGE.
For C-terminal labeling of a protein on a larger scale, we load the column with the desired 
substrate protein bearing a sortase-recognition motif LPXTG at its C-terminus (where X can 
be any amino acid, although typically glutamic acid is used) (Fig. 5) together with an 
oligoglycine probe harboring the functional group to be conjugated onto the protein.
For N-terminal labeling, we use a similar approach (Fig. 6). Here, the column is preloaded 
with a LPETGG-containing peptide, decorated with the substituent of choice at its N-
terminus. This allows the acyl intermediate to form on-resin, prior to incubation with the 
Glyn–modified substrate protein to be labeled. This preincubation step is essential to 
increase the yield of labeled product.
MATERIALS
REAGENTS
Overall Caution—For all items marked with a ! Caution marker, please use proper 
personal protection equipment (PPE; gloves, eye protection, and proper attire). Use of these 
chemicals should be carried out in a fume hood when possible. For more information, please 
refer to each item’s Material Safety Data Sheet (MSDS)
• Cyanogen bromide-activated-Sepharose 4B (e.g. Sigma-Aldrich, cat. no. C-9142)
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• Hydrochloric acid (HCl; EMD Millipore, cat. no. HX0603) ! CAUTION Toxic/
corrosive
• Sortase A or the heptamutant sortase A (expressed and purified as described20. 
Plasmids are available from Addgene, cat. no. 51138 and 51141)
• Sodium Chloride (American Bioanalytical, cat. no. AB01915)
• Sodium Bicarbonate (American Bioanalytical, cat. no. AB01929)
• Glycine (Sigma, cat. no. 67126)
• Tris Base (American Bioanalytical, cat. no. AB02000)
• Tris-HCl (American Bioanalytical, cat. no. AB02005)
• Common reagents for SDS-PAGE analysis
• Brilliant blue R (Sigma-Aldrich, cat. no. B7920)
• Methanol (MeOH; EMD, cat. no. MX0488) ! CAUTION Toxic/flammable
• Acetic acid (AcOH; VWR, cat. no. BDH3094) ! CAUTION Corrosive/flammable
• CaCl2 (EMD, cat. no 208290)
• For C-terminal labeling: Purified target protein (LPETGGHHHHHH at the C-
terminus at a 220 μM concentration in Tris-buffered saline (TBS)
• For C-terminal labeling: N-terminal oligoglycine peptide probe: 20 mM in water 
(synthesis described elsewhere20)
• For N-terminal labeling: Purified protein to be used as nucleophile (GGG at the N-
terminus)
• For N-terminal labeling: LPXTGG peptide probe: 20 mM stock solution in water, 1 
mM solution for reactions (synthesis described in elsewhere21).
• Triglycine (Sigma, cat. no. G1377)
• Ethanol (Pharmco-AAPER, cat. no. 111000190) ! CAUTION Flammable
• Nickel-nitrilotriacetic acid agarose suspension (Ni-NTA agarose; Qiagen, cat. no. 
30230)
• Imidazole (Alfa Aesar, cat. no. A10221) ! CAUTION Harmful
• Sample loading LDS-buffer, 4× (Invitrogen, cat. no. NP0008)
EQUIPMENT
• Amicon ultra concentrators 3 or 10 kDa MW cutoff (Millipore, cat. no. 
UFC900324 and UFC901024). The cut off range is dependent on the size of the 
protein being labeled.
• Dialysis cassettes (Thermo Scientific, cat. no. 66330 or 66110)
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• 25 mL polypropylene gravity columns with fritted bottom (Bio-Rad, cat. no. 732–
1010)
• Rotating mixer/shaker
• Tubes or vials for immobilized sortase storage
• GE Healthcare, Tricorn 5/100 column
• Micropipettes (5–1000 L)
• Centrifuge that supports centrifugation at 2080g
• 37°C incubator
• 1.5 mL centrifuge tubes
• Corning Costar spin-X centrifuge tube filters (SIGMA, cat. no. CLS8161)
• Superdex 75 (10/300 GL)
• Heating block
• Centrifuge that supports centrifugation at 2500g
• GENIE Plus syringe pump (Kent scientific)
REAGENT SETUP
• Sepharose swelling buffer: 1 mM HCl in water, store at 4 °C
• NaHCO3/NaCl coupling buffer: 0.1 M NaHCO3 pH 8.3, 0.5 M NaCl
• AcOH/NaCl buffer: 0.1 M AcOH pH 4.0, 0.5 M NaCl
• Blocking solution: 0.2 M glycine in water
• TBS buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl
• Coomassie blue staining: Dissolve 1.25 g Brilliant Blue R in a mixture of 
methanol (200 mL), water (250 mL) and acetic acid (50 mL). Store in a dark 
container at RT.
• Destaining solution: Mix water, ethanol and acetic acid in a ratio of 6:3:1. Store at 
RT.
• Sortase reaction buffer: 500 mM Tris-HCl, pH 7.4, 1.5 M NaCl, 100 mM CaCl2. 
(10× stock).
• Purification buffer: 50 mM Tris-HCl, pH 7.5, 150 mM NaCl. Store at 4 °C.
• Column washing solution: 1 mM triglycine, 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 10 mM CaCl2
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PROCEDURE
Part 1 - IMMOBILIZATION OF SORTASE TIMING 8–9 hours
1| Take 30 mg of stock sortase A or heptamutant sortase A and exchange the buffer 
to NaHCO3/NaCl coupling buffer through dialysis or with spin concentrators. 
Dilute the sortase to a total volume of 7 mL of coupling buffer.
2| Split 1 g of dry cyanogen-bromide activated Sepharose into two 25 mL 
polypropylene gravity flow columns.
3| Add 20 mL of cold 1 mM HCl swelling solution to each column and cap each 
end. Incubate for 7 min at 4 °C rotating in an end-over-end mixer. After 
uncapping, gently vacuum the liquid through the bottom frit. Repeat this step 5 
times.
Note: Good swelling of the Sepharose beads is required to obtain good 
immobilization efficiencies.
CRITICAL STEP: Do not let the beads dry out.
4| Combine the beads into one column and flow 200 mL of cold distilled water 
through the column with vacuum at 4 °C to wash the beads.
5| Flow through with vacuum 10 mL of NaHCO3/NaCl coupling buffer at 4 °C.
6| Immediately after washing add the 7 mL of sortase A solution from step 1 
Remove a small amount (~50 μL) of the supernatant for coupling efficiency 
analysis (step 15). Rotate in an end-over-end mixer at RT (room temperature, 
20–25 °C), for 2 h.
PAUSE POINT: The coupling can be done at 4 °C overnight.
CRITICAL STEP: Avoid amine-containing buffers, such as TRIS, or other 
nucleophilic buffers, as they will react with cyanogen bromide-activated 
Sepharose.
7| Remove the supernatant by gravity flow and carefully collect it to keep as a 
control (step 15).
8| Flow through 20 mL NaHCO3/NaCl coupling buffer using vacuum to wash the 
resin.
9| Modify any remaining unreacted cyanate ester groups with 15 mL blocking 
solution for 2 hours at RT, rotating in an end-over-end shaker.
PAUSE POINT: The blocking step may be carried out for 16 h at 4 °C.
10| Flow through 15 mL ice-cold NaHCO3/NaCl coupling buffer using vacuum to 
wash the resin.
11| Flow through with vacuum 15 mL 0.1 M AcOH/NaCl buffer at pH 4 to wash the 
resin.
12| Repeat steps 10 and 11 five times.
Witte et al. Page 7
Nat Protoc. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
13| Flow through 15 mL of ice-cold TBS buffer using vacuum to wash the resin, 
Repeat this step three times.
14| Resuspend the beads with an equivalent volume of TBS buffer to obtain a 50% 
slurry and transfer to a tube or vial for long term storage.
PAUSE POINT: Immobilized sortase from S. aureus can be stored at 4 °C for 3 
months or until degradation or loss of efficency is observed. The heptamutant 
sortase has a shorter lifetime of 3–4 weeks. Longer storage at 4 °C in the 
absence of a bacteriostatic or bactericidal is not recommended, as the protein 
may degrade or contamination may occur. The resin can be frozen in 20% 
glycerol at −20 °C or lyophilized in the presence of sucrose and stored at −20°C 
for even longer periods. For freeze-drying, we recommend gradually freezing 
the slurry at −20 °C before lyophilizing to minimize damage to the beads. After 
reconstitution, wash the resin with TBS buffer.
15| Analyze aliquots of the supernatant taken before and after immobilization (from 
steps 6 and 7) by SDS-PAGE to estimate sortase A coupling efficiency and the 
concentration of enzyme that is immobilized on the beads. It will be beneficial 
to create a serial dilution of the initial sample to achieve a better coupling 
efficiency estimate. The coupling efficiency should be 90–100%.
16| You can now either use the beads for small-scale batch labeling reaction to test 
their function and determine optimal reaction conditions (perform the steps in 
Part 2); or, if you are already satisfied that the beads will perform their function, 
flow reactions for large scale protein production (perform the steps in Part 3).
Part 2 - BATCH LABELING USING IMMOBILIZED SORTASE A: Optimization of the batch 
reaction
TIMING 1.5 days
17| Add 20–150 μM of immobilized sortase A (~7.5 mg mL−1 resin, 300 μM) or 5–
25 μM of immobilized heptamutant sortase A (~7.5 mg mL−1 resin, 440 μM) to 
a solution containing 10–50 μM target protein and 1–2 mM peptide probe in 1× 
sortase buffer (final concentrations). The final reaction volume should be at least 
100 μL.The controls to be included are: (a) resin only, (b) target protein only, (c) 
probe only, (d) target protein combined with the resin, (e) probe combined with 
the resin and (f) probe combined with the target protein (in the absence of resin).
Reactions may be performed in PBS (instead of sortase buffer) if using the 
heptamutant sortase A.
Note: Removal of aliquots from the supernatant to monitor the reaction (see step 
18) will increase the concentration of the immobilized sortase A. Use a reaction 
volume of 100 μL to minimize concentration increase and to allow direct 
comparison with sortase A reactions in solution.
18| Swirl the beads using an end-over-end shaker or thermomixer (800 rpm) and 
take aliquots (2 μL) from the supernatant after 1, 2, 4, 8 and 16h.
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Note: Different temperatures have to be screened to arrive at the optimal 
reaction conditions. For the regular sortase A, the optimal reaction temperature 
is between RT and 37°C. The heptamutant sortase is active at reduced 
temperatures. Most commonly, heptamutant reactions are performed between 15 
°C and RT although temperatures as low as 4 °C can be used for particularly 
sensitive experiments.
19| Remove the beads by centrifuging through spin filters at 280g, 5 min, 4 °C. 
Recover the supernatant and immediately denature the proteins by adding 1× 
LDS sample buffer and boiling for 2 min. The beads may be washed several 
times with TBS buffer and saved for further use.
20| Analyze the samples by SDS-PAGE followed by fluorescence scanning, western 
blot or Coomassie staining, depending on the probe being used.
21| Purification of the batch reaction. Repeat the batch reaction using the 
optimized reaction time and temperature. Use a reaction volume of 100 μL 
minimum.
22| Transfer the reaction to a centrifuge tube filter, centrifuge at 280g, 5 min, 4 °C 
and collect the fluid phase.
23| Wash the resin beads with 1× sortase buffer, centrifuge again, and collect the 
fluid phase.
Note: The beads may be stored at 4 °C in TBS buffer and may be reused until 
degradation or loss of activity it observed (as evidenced by decreased 
conversion of the substrate on Coomassie staining, fluorescence staining or 
western blot).
24| Combine the yield from steps 22 and 23.
25| Load the protein onto a previously washed and equilibrated size exclusion 
column Superdex 75 (10/300 GL). Elute the protein with 25 mL purification 
buffer at a flow rate of 0.5 mL h−1.
26| Collect 1.3 mL fractions and combine the positive fractions for protein (based 
on the UV spectra). Concentrate using an Amicon concentrator at 2080g at 4°C.
PAUSE POINT: Final storage depends on the stability of the protein being 
labeled.
Usually 4 °C for short-term, while −20°C or −80°C with 10% glycerol is 
optimal for longer durations
Part 3 - Protein labeling by flow reactions TIMING 7–16 h
27| To pack a column of immobilized sortase A, carefully resuspend the 
immobilized sortase A slurry to obtain a homogenous solution. Then pack the 
suspension of immobilized sortase A into a 5 × 100 mm column following the 
manufacturer’s protocol. Final loading volume is 5 × 70 mm immobilized 
sortase A (bead bed) containing 10 mg of protein.
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28| Flow through 3 mL of TBS buffer to wash the column.
PAUSE POINT: The column can be stored at 4 °C, for up to 3 months for 
sortase A. Columns containing the immobilized heptamutant variant can be 
stored for 3 weeks. The column can be reused many times until loss of activity 
or degradation is observed.
29| For large-scale protein labeling experiments follow the steps in option A if you 
want to do C-terminal labeling, or option B if you want to do N-terminal 
labeling.
A C-TERMINAL LABELING (LPXTG-CONTAINING PROTEIN) TIMING
i. Wash the column with 3 mL of 1× sortase buffer.
ii. Incubate the column at 37 °C and wait 2 h before proceeding to the next step. If 
using the heptamutant sortase the temperature may be reduced.
iii. Mix the protein substrate (345 μL of a 220 μM stock), the oligoglycine probe (150 
μL of a 20 mM stock), 10× sortase reaction buffer (300 μL), and water (2205 μL) in 
a centrifuge tube.
iv. Inject the reaction mixture in the sortase A-immobilized column at a flow rate of 
0.5 mL h−1 using a syringe pump at 37 °C. Collect the eluate.
v. Inject 1.5 mL of 1 mM of the oligoglycine peptide in 1× sortase reaction buffer 
after the final amount of protein substrate has flowed through the column. Collect 
the eluate.
vi. Combine the eluate from steps iv and v. vii. Purify the protein by gel filtration (see 
Steps 30–31) and regenerate the column as described in Steps 32–33.
B N-terminal protein labeling (GGG-containing protein) TIMING
i. Prepare solution A by mixing 300 μL of LPETG-containing probe (1 mM), 150 μL 
10× sortase buffer, and 1050 μL deionized water (total volume 1500 μL).
ii. Prepare solution B by mixing 450 μL of the GGG N-terminal protein (55 μM), 600 
μL of LPETG containing probe (1 mM), 300 μL of 10× sortase buffer, and 1650 μL 
of deionized water (total volume 3000 μL).
iii. Inject solution A into the immobilized sortase A column. Store the column at 37 °C 
for 0.5 h. Note: This step allows the LPETG containing probe to fully react with the 
sortase to pre-form the LPET-sortase covalent intermediate. If using the 
heptamutant sortase the temperature may be reduced.
iv. Pass mixture B through the column at a flow rate of 0.5 mLh−1. Collect 0.5 mL 
fractions from the column.
v. Reinject the void volume (0.9 mL) back through the column at 0.5 mLh−1 to elute 
any remaining free protein.
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vi. Combine the fractions from the column and concentrate using an Amicon 
concentrator at 2080g at RT.
vii. Purify the protein by gel filtration (see Steps 30–31) and regenerate the column as 
described in Steps 32–33.
30| Purification of the labeled protein. Load the concentrated protein onto a 
previously washed and equilibrated size exclusion column Superdex 75 (10/300 
GL) and elute the proteins with 25 mL eluting solution at a flow rate of 0.5 mL 
h−1.
31| Collect 1.3 mL fractions and combine the positive fractions for protein (based 
on the UV spectra). Concentrate using a centrifugal concentrator at 2500g at 
4°C.
PAUSE POINT: Final storage depends on the stability of the protein being 
labeled.
Usually 4 °C for short-term (3 days), while −20°C or −80°C with 10% glycerol 
is optimal for longer durations.
32| Regeneration of the immobilized sortase column. Wash the immobilized 
sortase column with 3 mL of column washing solution at 30 mLh−1
33| Wash the column with 3 mL of TBS buffer by hand injection.
PAUSE POINT: The column can be stored at 4 °C until the next sortase 
reaction.
TIMING
Steps 1–5, 1.5 h
Steps 6–8, 2.5 h
Steps 9–15, 3–4 h
Steps 16–20, 1 d
Steps 21–26, 4 h
Steps 27–28, 1h
Step 29 A: Steps i–ii 1–2 h, Steps iii-x 7–8 h, Steps xi–xii 3–4 h
Step 29B: Steps i–v 1.5 h, Steps v–viii 2.5 h, Steps ix–xv 3–4 h
Steps 30–31, 1.5–4 h
Steps 32–33, 30 min
TROUBLESHOOTING
See Table X for troubleshooting guidelines.
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ANTICIPATED RESULTS
The anticipated loading of the resin using the above described conditions is approximately 
7.5 mg of sortase A per milliliter of packed resin, and this resin can be stored for several 
weeks to months at 4 °C depeding on the used sortase variant.
A successful sortase reaction will result in the formation of product, which, depending on 
the probe used, can be visualized by fluorescence scanning (if using a fluorescent dye), 
western-blot (if using biotin or an affinity tag) or Coomassie staining (if substrate and 
product differ in apparent MW sufficiently to be visualized by SDS-PAGE). Figures 3 and 4 
present a successful batch C-terminal and N-terminal labeling reaction, using immobilized 
heptamutant sortase A and sortase A respectively. Sortase A should not be visible in any of 
the samples, as it is immobilized and removed by filtration/centrifugation in the case of 
batch reactions. Since an acyl intermediate may form, a decrease in protein signal is 
expected in the control samples containing just the target protein and immobilized sortase 
when performing C-terminal labeling. On some occasions proteins will non-specifically bind 
to the resin. This can be inferred by comparing the amount of protein obtained upon reaction 
with the amount of input material.
For large scale flow reactions, we typically use a flow rate of 0.5 mL/h with a residence time 
of the protein on the column of 2 h. Under these conditions we obtain a yield in the range of 
65–90% of purified labeled protein. Reaction rates and flow rates are protein-dependent and 
need to be determined empirically prior to scaling up the reaction.
Troubleshooting
Troubleshooting guidelines can be found in Table 1.
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SUMMARY
Sortase A can be used for the site-specific modification of proteins. This protocol 
describes its immobilization on sepharose beads allowing for larger scale flow reactions 
or easy separation from the enzyme in batch reactions.
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Figure 1. Schematic representation of the sortase immobilization on Sepharose beads
Free amines of sortase A react with the activated ester, forming an iso urea or an 
imidocarbonate derivate.
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Figure 2. Comparison of wildtype (WT), pentamutant (5M) and heptamutant (7M) Srt A activity 
in the presence or absence of Ca2+
In this experiment, 30 μM VHHF4-LPETG-6xHis , 0.5 mM GGG-TAMRA and 5 μM of the 
appropriate sortase were incubated at 4 °C for the indicated time in either (+ Ca2+) 50 mM 
Tris, pH 7.5, 150 mM NaCl supplemented with 10 mM CaCl2 or (− Ca2+) PBS 
supplemented with 10 mM EGTA. Equal amounts of the reaction mixtures were loaded on a 
15% SDS-page gel. The mixtures were analyzed usign in gel fluorescence scanning with 
emission filter 580 nm (b) and staining with coomassie brilliant blue (a). The band at 15 kD 
in the fluorescence image corresponds to TAMRA labeled VHHF4. No fluorescent signal is 
observed for WT Srt A.
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Figure 3. Comparison of C-terminal specific labeling of a LPETG containing streptavidin 
protein with a Gly3-TAMRA fluorophore using immobilized heptamutant sortase A (batch) or 
heptamutant sortase A in solution
The LPETG containing streptavidin and Gly3-TAMRA were prepared as described in the 
protocol, as well as the expression and immobilization of sortase A. In this experiment, 50 
μM LPETG containing streptavidin and 2 mM Gly3-TAMRA were incubated overnight with 
either 25 μM immobilized sortase A (lane 1) or 10 μM sortase A in solution (lane 2). The 
equal amounts of the reaction mixtures were loaded on a 15% SDS-page gel and stained 
with coomassie brilliant blue (a). In gel fluorescence scanning with emission filter 580 nm 
yielded image b. TAMRA labeled product was only found in the lanes containing sortase, 
protein, and probe. This gel confirms that immobilization of sortase A did not compromise 
its activity. The coomassie-stained image A illustrates the absence of sortase A in solution, 
when using immobilized sortase A for the reaction.
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Figure 4. Comparison of N-terminal specific labeling of a Gly3 containing Cholera toxin B 
(CtxB) with a LPETG containing TAMRA fluorophore using immobilized sortase A (batch) or 
sortase A in solution
The LPETG containing TAMRA and Gly3-CtxB were prepared as described in the protocol, 
as well as the expression and immobilization of sortase A. In this experiment, 50 μM 
LPETG containing TAMRA and 30 μM Gly3-CtxB were incubated overnight with either 50 
μM immobilized sortase A (lane 1) or 50 μM sortase A in solution (lane 2). The equal 
amounts of the reaction mixtures were loaded on a 15% SDS-page gel. The mixtures were 
analyzed after in gel fluorescence scanning with emission filter 580 nm (b) and staining with 
coomassie brilliant blue (a). The two fluorescent bands around 10 kD (lanes 1–2) in the 
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fluorescence image indicate near complete conversion to the labeled product. The 
coomassie-stained image A illustrates the absence of sortase A in solution, when using 
immobilized sortase A for the reaction.
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Figure 5. C-terminal labeling of proteins using immobilized sortase
A protein C-terminally modified with the LPXTG motif and a peptide probe containing a 
series of N-terminal glycine residues are injected onto a column with S. aureus sortase A 
immobilized on Sepharose beads. Sortase forms an acyl-enzyme intermediate with Thr on 
the protein’s recognition motif. Nucleophilic attack of the peptide probe resolves the 
intermediate, thus ligating the peptide probe to the C-terminus of the protein and 
regenerating the active site Cys on sortase. Labeled protein is eluted from the column.
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Figure 6. N-terminal labeling of proteins using immobilized sortase
A protein N-terminally modified with a series of glycine residues and a peptide probe 
containing C-terminal LPXTG S. aureus motif are injected onto a column with S. aureus 
sortase A immobilized on Sepharose beads. Sortase forms an acyl-enzyme intermediate with 
Thr residue within the peptide’s recognition motif. Nucleophilic attack of the protein 
resolves the intermediate, thus ligating the peptide probe to the N-terminus of the protein 
and regenerating the active site Cys on sortase. Labeled protein is eluted from the column.
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Table 1
Troubleshooting
Problem Possible reason Solution
Poor immobilization The cyanogen bromide-activated 
Sepharose is no longer reactive
Check the expiration date of the Sepharose
The protein is diluted in a buffer 
incompatible for immobilization
Avoid the use of amine- containing buffers
Incomplete conversion for C- terminal 
protein modification
Wrong buffer The buffer pH should be ~ pH 7.5. If S. aureus Sortase 
A is used the buffer should contain 1mM CaCl2 and 
phosphate-based buffers should be avoided.
The ratio between the C-terminal 
protein-LPXTGG and GGG-label is not 
optimal.
Increase the amount of nucleophile. The conditions need 
to be determined empirically.
Sortase is degraded Prepare a fresh batch of immobilized sortase.
C-terminus is not well exposed Extend the C-terminus of the protein introducing a 
linker (Gly4Ser)2 immediately upstream of the sortase 
motif.
The protein to be labeled is not a 
suitable substrate for sortase
Reaction conditions should be tested in batch using 
soluble and immobilized enzyme, before scaling up to 
the continuous-flow system.
Hydrolysis of the C-terminal LPXTGG 
protein
Although uncommon, this may occur more frequently 
with the heptamutant sortase. Lower the amount of 
sortase added. Alternatively, reduce the temperature 
and/or reaction time.
Incomplete conversion for N- terminal 
protein modification
No acyl-intermediate was formed Load the LPXTGG-containing (poly)peptide on the 
immobilized sortase column and let incubate at 37°C for 
1 – 2 h.
The ratio between the N-terminal 
protein-LPXTGG and GGG-protein is 
not optimal.
Decrease the amount of injected protein or increase the 
amount of LPXTGG probe for the incubation.
The flow rate may be too high or too 
low.
Use SDS-PAGE to check the conversion rate and adjust 
the flow rate.
Sortase is degraded Prepare a fresh batch of immobilized sortase.
N-terminus is not exposed Increase the length of the Glyn N- terminus
The protein to be labeled is not a 
suitable substrate for sortase
Reaction conditions should be tested in batch using 
soluble and immobilized enzyme, before scaling up to 
the continuous-flow system.
Hydrolysis of the LPXTGG probe This may occur more frequently with the heptamutant 
sortase. Reduce the temperature and/or reaction time.
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